News & Events

object(WP_Post)#21516 (24) { ["ID"]=> int(29137) ["post_author"]=> string(1) "2" ["post_date"]=> string(19) "2022-07-22 14:58:46" ["post_date_gmt"]=> string(19) "2022-07-22 13:58:46" ["post_content"]=> string(902) "The Drug Delivery to the Lungs DDL 2022 conference returns to Edinburgh, UK as an in-person event for the first time in two years. We look forward to supporting the conference as Gold sponsors. As a leading conference and industry exhibition dedicated to pulmonary drug delivery, DDL offers researchers a forum for presenting recent developments in the field of inhalation therapy through both podium and poster presentations. The three-day conference consists of a programme of lectures covering five session themes, providing attendees with a space for meeting colleagues, discussing research and networking with leading inhaler testing solution and service providers. To arrange a meeting with a member of the Copley team during DDL 2022, please contact us at sales@copleyscientific.co.uk." ["post_title"]=> string(35) "Drug Delivery to the Lungs DDL 2022" ["post_excerpt"]=> string(32) "7th December - 9th December 2022" ["post_status"]=> string(7) "publish" ["comment_status"]=> string(6) "closed" ["ping_status"]=> string(6) "closed" ["post_password"]=> string(0) "" ["post_name"]=> string(35) "drug-delivery-to-the-lungs-ddl-2022" ["to_ping"]=> string(0) "" ["pinged"]=> string(0) "" ["post_modified"]=> string(19) "2022-07-25 09:46:48" ["post_modified_gmt"]=> string(19) "2022-07-25 08:46:48" ["post_content_filtered"]=> string(0) "" ["post_parent"]=> int(0) ["guid"]=> string(63) "https://www.copleyscientific.com/?post_type=events&p=29137" ["menu_order"]=> int(0) ["post_type"]=> string(6) "events" ["post_mime_type"]=> string(0) "" ["comment_count"]=> string(1) "0" ["filter"]=> string(3) "raw" }

object(WP_Post)#21519 (24) { ["ID"]=> int(23079) ["post_author"]=> string(1) "2" ["post_date"]=> string(19) "2022-04-28 10:14:43" ["post_date_gmt"]=> string(19) "2022-04-28 09:14:43" ["post_content"]=> string(4319) "28 April 2022; Nottingham, UK: Copley Scientific, the global leader in inhaled product testing equipment, has launched the new Gentle Rocker 100i, a simple, cost-effective device that boosts the productivity and repeatability of aerodynamic particle size distribution (APSD) measurements with the Next Generation Impactor (NGI). APSD is a critical quality attribute for all orally inhaled and nasal drug products (OINDPs) and routinely measured with the NGI. The new Gentle Rocker 100i offers:

• Method flexibility, enabling agitation at speeds across the range 10 to 60 rpm
• Touchscreen operation with clearly displayed test parameters, time elapsed monitoring and audible alarm options
• Convenient tilting functionality to facilitate effective solution sampling post drug recovery
• Efficient reporting including data transfer to printer or PC
• An optional evaporation cover (with seals) for volatile solvent handling.

The recovery of drug from each collection cup is a critical but time-consuming element of APSD measurement with the NGI. It involves dispensing a defined aliquot of solvent into each cup, followed by agitation to ensure complete drug dissolution. The Gentle Rocker 100i holds a full tray of collection cups and applies a consistent, defined agitation pattern to ensure well-controlled and complete drug dissolution. It enables the application of specific, reproducible methods and easy method transfer, delivering reliable results and a lighter analytical workload. The Gentle Rocker 100i is just one of a range of semi-automation tools that Copley provides for inhaled product testing. Together these products support a stepwise approach to the automation of test methods that remain predominantly manual in many labs. This approach minimizes risk while maximizing return on investment and maintaining the flexibility to test multiple products. Find out more about Copley’s portfolio of semi-automation tools for inhaler testing and how they can help you to achieve higher productivity and reproducibility.

ENDS

CAPTION: The new Copley Gentle Rocker 100i is a simple tool for drug recovery for the NGI that boosts the efficiency of inhaler testing.

  About Copley Scientific Copley Scientific is widely recognised as the world’s leading manufacturer and supplier of inhaler test equipment and is a major provider of testing systems for other pharmaceutical dosage forms. The company also supplies equipment for detergent testing. Copley’s pharmaceutical product range includes test equipment for all types of orally inhaled and nasal drug products - metered-dose inhalers, dry powder inhalers, nebulisers and nasal sprays - with a particular focus on solutions for delivered dose uniformity and aerodynamic particle size distribution measurement. It also includes testers for tablets (dissolution, disintegration, friability and hardness) capsules, powders, suppositories, semisolids and transdermals. Used from R&D through to QC, this extensive range of equipment is supported by a full validation and aftersales service. Copley Scientific has offices in the UK and Switzerland and works in partnership with aerosol particle science experts MSP Corporation in North America; specialist distributors extend localised support across the world. This network provides expert help and training to every customer, directly enhancing the application of all Copley products. www.copleyscientific.com" ["post_title"]=> string(70) "Copley launches a new semi-automation tool for inhaled product testing" ["post_excerpt"]=> string(0) "" ["post_status"]=> string(7) "publish" ["comment_status"]=> string(6) "closed" ["ping_status"]=> string(4) "open" ["post_password"]=> string(0) "" ["post_name"]=> string(34) "copley-launches-gentle-rocker-100i" ["to_ping"]=> string(0) "" ["pinged"]=> string(0) "" ["post_modified"]=> string(19) "2022-04-28 10:16:48" ["post_modified_gmt"]=> string(19) "2022-04-28 09:16:48" ["post_content_filtered"]=> string(0) "" ["post_parent"]=> int(0) ["guid"]=> string(41) "https://www.copleyscientific.com/?p=23079" ["menu_order"]=> int(0) ["post_type"]=> string(4) "post" ["post_mime_type"]=> string(0) "" ["comment_count"]=> string(1) "0" ["filter"]=> string(3) "raw" }

object(WP_Post)#21510 (24) { ["ID"]=> int(16792) ["post_author"]=> string(1) "2" ["post_date"]=> string(19) "2021-10-26 10:23:23" ["post_date_gmt"]=> string(19) "2021-10-26 09:23:23" ["post_content"]=> string(5197) "26 October 2021; Nottingham, UK: The latest accessory from Copley Scientific, the global leader in inhaled product testing equipment, simplifies the measurement of delivered dose uniformity for nasal drug products in accordance with the recently revised specifications in European Pharmacopoeia (Ph. Eur.)¹ Chapter 0676 and US Pharmacopoeia (USP) Chapter <601>². The new nasal dose uniformity sampling apparatus (DUSA) interface plate enables simple, leak-free connection between a standard DUSA and the nasal drug product to ensure complete dose capture. Designed for use with a Vertus II/Plus, Copley’s automated shake and fire system, it supports automated, high productivity, high repeatability testing. Introduction of the new interface means that all routine test set-ups for nasal drug products are now easily automated using Copley’s complete integrated solution. Dose uniformity is a critical quality attribute for nasal drug products because of its direct impact on clinical efficacy. Dose uniformity measurements involve vertical or near vertical firing of the nasal drug product and capture of the released dose. Leakage and loss of dose, back on to the product nozzle, is a common problem, as is variability arising from manual product actuation. The Vertus II/Plus is a well-established fully automated shake and fire system for nasal drug product actuation. Automated actuation of the nasal drug product reduces analytical variability, at the same time improving test productivity and reducing health and safety risks for analysts. With the introduction of the new interface, the Vertus II/Plus can now be used with:

• A standard metered dose inhaler DUSA – as specified in recent revisions to the Ph. Eur. and USP, which are more prescriptive than preceding versions with respect to dose capture.
• A Nasal Spray Dose Collector – an accessory designed specifically for nasal drug product testing that combines highly efficient drug capture and ease-of-use.
• A Nasal Spray Waste Collector – for firing to waste under representative conditions.

Together these products represent a complete solution for dose uniformity for nasal drug product dose uniformity testing. Furthermore, the Vertus II/Plus can be interfaced with any routinely used cascade impactor, via an expansion chamber or Alberta Idealised Nasal Inlet, to measure the aerodynamic particle size distribution of the respirable fraction of the dose, to assess the risk of drug delivery via the lungs. Such testing is recommended by the regulators for both new and generic products. To find out more about Copley’s full range for nasal drug product testing and how it can help with faster, more effective product development go to www.copleyscientific.com. ¹ Ph. Eur. 10.5 Nasal Preparations, Nasalia. 01/2021:0676. ² USP Chapter <601> ‘Aerosols, Nasal Sprays, Metered Dose Inhalers and Dry Powder Inhalers’

ENDS

CAPTION: The new nasal DUSA interface combines with the Vertus II/Plus to provide an efficient, productive, easy-to-use solution for nasal spray drug product testing.

  About Copley Scientific Copley Scientific is widely recognised as the world’s leading manufacturer and supplier of inhaler test equipment and is a major provider of testing systems for other pharmaceutical dosage forms. The company also supplies equipment for detergent testing. Copley’s pharmaceutical product range includes test equipment for all types of orally inhaled and nasal drug products - metered-dose inhalers, dry powder inhalers, nebulisers and nasal sprays - with a particular focus on solutions for delivered dose uniformity and aerodynamic particle size distribution measurement. It also includes testers for tablets (dissolution, disintegration, friability and hardness) capsules, powders, suppositories, semisolids and transdermals. Used from R&D through to QC, this extensive range of equipment is supported by a full validation and aftersales service. Copley Scientific has offices in the UK and Switzerland and works in partnership with aerosol particle science experts MSP Corporation in North America; specialist distributors extend localised support across the world. This network provides expert help and training to every customer, directly enhancing the application of all Copley products. www.copleyscientific.com" ["post_title"]=> string(84) "New accessory completes Copley’s solution for automated nasal drug product testing" ["post_excerpt"]=> string(0) "" ["post_status"]=> string(7) "publish" ["comment_status"]=> string(6) "closed" ["ping_status"]=> string(4) "open" ["post_password"]=> string(0) "" ["post_name"]=> string(32) "dusa-interface-plate-nasal-spray" ["to_ping"]=> string(0) "" ["pinged"]=> string(0) "" ["post_modified"]=> string(19) "2022-02-16 14:28:50" ["post_modified_gmt"]=> string(19) "2022-02-16 14:28:50" ["post_content_filtered"]=> string(0) "" ["post_parent"]=> int(0) ["guid"]=> string(41) "https://www.copleyscientific.com/?p=16792" ["menu_order"]=> int(0) ["post_type"]=> string(4) "post" ["post_mime_type"]=> string(0) "" ["comment_count"]=> string(1) "0" ["filter"]=> string(3) "raw" }

object(WP_Post)#21490 (24) { ["ID"]=> int(14160) ["post_author"]=> string(1) "2" ["post_date"]=> string(19) "2021-06-22 13:29:29" ["post_date_gmt"]=> string(19) "2021-06-22 12:29:29" ["post_content"]=> string(4964) "23 June 2021; Nottingham, UK: Copley Scientific has joined the Industries Forum of the Taskforce for Lung Health. The Taskforce is a collaboration of over 30 members including patients, health care professionals, the voluntary sector and professional associations all working together to represent the needs of people with lung disease. The Taskforce’s Industries Forum is a group of representatives from the pharmaceutical, diagnostics, devices, and digital industries that works alongside the Taskforce to improve the diagnosis, treatment, and care of patients living with lung disease in England. Company experts will join regular meetings of the Industries Forum to share relevant industry views, intelligence, and experience. As the world’s leading manufacturer and supplier of inhaler test equipment, Copley brings unique perspective on the safety and quality issues associated with inhaler testing and use. The Taskforce has established a five-year plan to improve all aspects of lung disease management from the preservation of good lung health, through to earlier, more effective disease diagnosis, and end of life care. Working groups focusing on Early Diagnosis, Medicines Optimisation, and Pulmonary Rehabilitation, help to implement the associated recommendations of the five year plan. These groups draw on a wide range of expertise from the Taskforce and the Industries Forum to ensure optimal solutions to some of the most demanding challenges associated with lung health. Copley, a family-owned UK company currently celebrating 75 years in business, develops and manufactures equipment for in vitro inhaler testing that is used to optimise the safety and efficacy of drugs for conditions such as asthma, COPD, and cystic fibrosis. Developing solutions that make in vitro testing more clinically representative is currently an important task, and a good example of the insight that Copley has to offer. Such solutions help researchers to efficiently build an increasingly accurate and detailed understanding of how to improve inhaled drug delivery and how patient physiology and technique impact its success. This knowledge informs better device design for specific patient groups and a more robust assessment of the potential for inadequate drug delivery, where technique is compromised. “We’re looking forward to investing in the very worthwhile work of the Taskforce for Lung Health,” said Mr Mark Copley, CEO, Copley Scientific. “Lung health is currently at the forefront of people’s minds, and I hope we can help to make real progress in patient outcomes. Copley occupies a distinctive position within the inhaled product research community, and we’re pleased to be able to contribute our insight and expertise to more directly support lung disease sufferers across England.” Learn more about the work of the Taskforce, here: https://www.blf.org.uk/taskforce

CAPTION: Copley is proud to announce joining the Taskforce for Lung Health as its newest Industries Forum member.

ENDS

 

About Copley Scientific

Copley Scientific is widely recognised as the world’s leading manufacturer and supplier of inhaler test equipment and is a major provider of testing systems for other pharmaceutical dosage forms. The company also supplies equipment for detergent testing. Copley’s pharmaceutical product range includes test equipment for all types of orally inhaled and nasal drug products - metered-dose inhalers, dry powder inhalers, nebulisers and nasal sprays - with a particular focus on solutions for delivered dose uniformity and aerodynamic particle size distribution measurement. It also includes testers for tablets (dissolution, disintegration, friability and hardness) capsules, powders, suppositories, semisolids and transdermals. Used from R&D through to QC, this extensive range of equipment is supported by a full validation and aftersales service. Copley Scientific has offices in the UK and Switzerland and works in partnership with aerosol particle science experts MSP Corporation in North America; specialist distributors extend localised support across the world. This network provides expert help and training to every customer, directly enhancing the application of all Copley products.  www.copleyscientific.com" ["post_title"]=> string(77) "Copley Scientific joins the Industries Forum of the Taskforce for Lung Health" ["post_excerpt"]=> string(0) "" ["post_status"]=> string(7) "publish" ["comment_status"]=> string(6) "closed" ["ping_status"]=> string(4) "open" ["post_password"]=> string(0) "" ["post_name"]=> string(77) "copley-scientific-joins-the-industries-forum-of-the-taskforce-for-lung-health" ["to_ping"]=> string(0) "" ["pinged"]=> string(0) "" ["post_modified"]=> string(19) "2021-06-23 08:49:15" ["post_modified_gmt"]=> string(19) "2021-06-23 07:49:15" ["post_content_filtered"]=> string(0) "" ["post_parent"]=> int(0) ["guid"]=> string(41) "https://www.copleyscientific.com/?p=14160" ["menu_order"]=> int(0) ["post_type"]=> string(4) "post" ["post_mime_type"]=> string(0) "" ["comment_count"]=> string(1) "0" ["filter"]=> string(3) "raw" }

object(WP_Post)#21506 (24) { ["ID"]=> int(12766) ["post_author"]=> string(1) "2" ["post_date"]=> string(19) "2021-03-18 12:05:46" ["post_date_gmt"]=> string(19) "2021-03-18 12:05:46" ["post_content"]=> string(5281) "18 March 2021; Nottingham, UK: Inhalytix™ is a completely new software solution from Copley, the global leader in inhaler testing equipment, that brings a standardised approach to cascade impactor data analysis, efficiently converting raw data into performance-defining metrics for all inhaled products. Cascade impactors determine aerodynamic particle size distribution (APSD), a critical quality attribute for inhaled drug delivery. Inhalytix™ is flexible, user configurable and suitable for all cascade impactors in routine use, for both standard and bespoke test set-ups and methods. It handles the entry, analysis and reporting of APSD data to company and regulatory standards, in accordance with draft USP Chapter <1603>, Ph.Eur. Chapter 2.9.18 and relevant US FDA guidance. The software also serves as a database for laboratory cascade impactor inventory enhancing data traceability and integrity. Cascade impaction involves quantitative recovery and chemical analysis (typically by HPLC) of the size fractionated aerosol from an inhaled product to generate a drug specific APSD. The technique generates substantial quantities of data. Inhalytix™ is the successor to Copley’s highly regarded CITDAS™ software, built from the ground-up, drawing on the company’s established expertise in this area. It uses the same core calculation protocols but offers significantly enhanced functionality allowing customers to configure:

• Reports – choosing which metrics to include to ensure the consistent and informative delivery of results, to meet regulatory requirements.
• Equipment – selecting from a library of test equipment to handle standard and complex equipment configurations.
• Methods – to combine detailed product information with reporting and equipment configurations, and to define metrics such as stage groupings and fine particle dose.

Interactive routine analysis, with a defined method, proceeds via a simple three-step process: Prepare, Execute and Analyse. Data can be entered manually or imported and comparison tools simplify assessment of the results, especially when comparing test and reference products in the case of generics. Using the equipment database users can link mensuration data, which quantifies changes in the critical dimensions of an in-use impactor, to specific, serialised impactors. This capability enhances data traceability and makes it possible to use actual rather than nominal dimensions to calculate APSDs, with greater accuracy. Inhalytix™ incorporates new metrics such as Impactor Sized Mass (ISM), Large Particle Mass (LPM), Small Particle Mass (SPM) and LPM/SPM ratio, amongst others and handles a broad array of impactors and components, including abbreviated impactors such as the Fast Screening Andersen (FSA). The software is 21 CFR Part 11 compliant with user access management and audit trails, and is also fully validated with a unique, built-in, auto-validation capability. Available in various expandable, multi-user licence configurations, Inhalytix™ can be either server, cloud or individual computer-based, enabling access in and away from the lab. Find out more about the capabilities of Inhalytix™ Here

CAPTION: Marking their 75th Anniversary, Copley are proud to launch Inhalytix™, a state-of-the-art, fully validated software package for generating APSD metrics in line with the latest pharmacopoeial specifications

ENDS

About Copley Scientific

Copley Scientific is widely recognised as the world’s leading manufacturer and supplier of inhaler test equipment and is a major provider of testing systems for other pharmaceutical dosage forms. The company also supplies equipment for detergent testing. Copley’s pharmaceutical product range includes test equipment for all types of orally inhaled and nasal drug products - metered-dose inhalers, dry powder inhalers, nebulisers and nasal sprays - with a particular focus on solutions for delivered dose uniformity and aerodynamic particle size distribution measurement. It also includes testers for tablets (dissolution, disintegration, friability and hardness) capsules, powders, suppositories, semisolids and transdermals. Used from R&D through to QC, this extensive range of equipment is supported by a full validation and aftersales service. Copley Scientific has offices in the UK and Switzerland and works in partnership with aerosol particle science experts MSP Corporation in North America; specialist distributors extend localised support across the world. This network provides expert help and training to every customer, directly enhancing the application of all Copley products. www.copleyscientific.com" ["post_title"]=> string(97) "Introducing Inhalytix™: a new solution for analysing and managing inhaler test data from Copley" ["post_excerpt"]=> string(0) "" ["post_status"]=> string(7) "publish" ["comment_status"]=> string(6) "closed" ["ping_status"]=> string(4) "open" ["post_password"]=> string(0) "" ["post_name"]=> string(93) "introducing-inhalytix-a-new-solution-for-analysing-and-managing-inhaler-test-data-from-copley" ["to_ping"]=> string(0) "" ["pinged"]=> string(0) "" ["post_modified"]=> string(19) "2021-07-07 09:06:45" ["post_modified_gmt"]=> string(19) "2021-07-07 08:06:45" ["post_content_filtered"]=> string(0) "" ["post_parent"]=> int(0) ["guid"]=> string(41) "https://www.copleyscientific.com/?p=12766" ["menu_order"]=> int(0) ["post_type"]=> string(4) "post" ["post_mime_type"]=> string(0) "" ["comment_count"]=> string(1) "0" ["filter"]=> string(3) "raw" }

object(WP_Post)#21508 (24) { ["ID"]=> int(12745) ["post_author"]=> string(1) "2" ["post_date"]=> string(19) "2021-03-11 13:22:58" ["post_date_gmt"]=> string(19) "2021-03-11 13:22:58" ["post_content"]=> string(5382) "11 March 2021, Nottingham, UK: Copley Scientific, the global leader in OINDP testing equipment, has introduced a series of new accessories that work with established products to deliver efficient, integrated solutions for measurement of the critical quality attributes of nasal sprays, aerosols, and powders. Currently the subject of intense research activity, particularly for generics manufacturers, nasal products deliver drugs for both local and systemic action. The new range of accessories allows customers to:

• Reproducibly measure the delivered dose uniformity (DDU) of nasal sprays, in line with regulatory requirements, using automated and manual methodologies.
• Easily establish robust, automated nasal drug product test set-ups to measure the aerodynamic particle size distribution (APSD) of the respirable fraction of the dose.
• Improve in vitro-in vivo correlations (IVIVCs) and study regional droplet deposition in the nasal cavity, to optimise drug delivery via a target pathway.

DDU measurement for nasal sprays calls for firing of the product into a vertically mounted sampling apparatus. The new Nasal Spray Dose Collector (NSDC) and Nasal Spray Waste Collector (NSWC) have been designed specifically for this purpose. While useful for manual DDU testing, they can be integrated with the Vertus II/Plus automated shake and fire system in a highly productive test set-up that maximises the reproducibility of DDU measurements while alleviating the health and safety risks associated with repeated manual nasal spray product operation. The new Alberta Idealised Nasal Inlet (AINI) is an important step forward in terms of achieving more clinically representative nasal product testing and is particularly valuable for the demonstration of bioequivalence. Building on the reputation of the Alberta Idealised Throat, the AINI was originally developed by Professor Finlay from the University of Alberta and has an idealised clinically validated geometry created from Computer Tomography (CT) scans of individual subjects. It is made up of four individual regions – the vestibule, turbinate, olfactory and nasopharynx – and mimics deposition behaviour in each while simultaneously generating a sample that accurately reflects the respirable dose. Manufactured from aluminium, the AINI has a robust, leak-free, easy-to-use design. It can be used with a filter, such as the Fine Fraction Collector, to quantitatively determine drug deposition by chemical recovery and assay or interfaced with a cascade impactor to representatively measure the APSD of the respirable fraction. Further accessories additionally enable interfacing of the Vertus II/Plus with any routinely used cascade impactor, via an expansion chamber or AINI, for representative measurement of the APSD of the sub-10 microns, respirable fraction of the dose. Such testing is essential to quantify the risk of drug delivery via the lung, rather than via the nasal cavity. As with DDU testing, use of the Vertus II/Plus with cascade impactors such as the Next Generation Impactor and Andersen Cascade Impactor for this application, reduces measurement variability, boosts productivity, and alleviates health and safety concerns. Find out more about the new nasal product testing portfolio and how it can accelerate nasal product development: www.copleyscientific.com

CAPTION: The Alberta Idealised Nasal Inlet enables the generation of drug deposition data for four specific regions of the nasal passageways and interfaces with all pharmacopoeia-recommended cascade impactors

ENDS

About Copley Scientific

Copley Scientific is widely recognised as the world’s leading manufacturer and supplier of inhaler test equipment and is a major provider of testing systems for other pharmaceutical dosage forms. The company also supplies equipment for detergent testing. Copley’s pharmaceutical product range includes test equipment for all types of orally inhaled and nasal drug products - metered-dose inhalers, dry powder inhalers, nebulisers and nasal sprays - with a particular focus on solutions for delivered dose uniformity and aerodynamic particle size distribution measurement. It also includes testers for tablets (dissolution, disintegration, friability and hardness) capsules, powders, suppositories, semisolids and transdermals. Used from R&D through to QC, this extensive range of equipment is supported by a full validation and aftersales service. Copley Scientific has offices in the UK and Switzerland and works in partnership with aerosol particle science experts MSP Corporation in North America; specialist distributors extend localised support across the world. This network provides expert help and training to every customer, directly enhancing the application of all Copley products.  www.copleyscientific.com  " ["post_title"]=> string(65) "Copley introduces a comprehensive range for nasal product testing" ["post_excerpt"]=> string(0) "" ["post_status"]=> string(7) "publish" ["comment_status"]=> string(6) "closed" ["ping_status"]=> string(4) "open" ["post_password"]=> string(0) "" ["post_name"]=> string(65) "copley-introduces-a-comprehensive-range-for-nasal-product-testing" ["to_ping"]=> string(0) "" ["pinged"]=> string(0) "" ["post_modified"]=> string(19) "2021-07-07 15:31:59" ["post_modified_gmt"]=> string(19) "2021-07-07 14:31:59" ["post_content_filtered"]=> string(0) "" ["post_parent"]=> int(0) ["guid"]=> string(41) "https://www.copleyscientific.com/?p=12745" ["menu_order"]=> int(0) ["post_type"]=> string(4) "post" ["post_mime_type"]=> string(0) "" ["comment_count"]=> string(1) "0" ["filter"]=> string(3) "raw" }

object(WP_Post)#21505 (24) { ["ID"]=> int(12566) ["post_author"]=> string(1) "2" ["post_date"]=> string(19) "2021-03-01 09:59:40" ["post_date_gmt"]=> string(19) "2021-03-01 09:59:40" ["post_content"]=> string(5229) "01 March 2021, Nottingham, UK: Copley Scientific, the global leaders in inhaler testing equipment, is marking the company’s 75th anniversary with a significant upgrade of its comprehensive, integrated range for measuring the critical attributes of orally inhaled and nasal drug products (OINDPs), notably delivered dose uniformity (DDU) and aerodynamic particle size distribution (APSD). The upgrade marks a major evolution in Copley’s offering which now includes:

• new products to meet defined customer needs, from tools for workflow management such as the Inhaler Testing Workstation (ITW) to an updated portfolio for nasal drug product testing
• re-engineered core ancillaries, substantially updated with an emphasis on ease-of-use, efficiency, and productivity
• Inhalytix™, a state-of-the-art, fully validated software package for generating APSD metrics in line with the latest pharmacopoeial specifications
• an expanded, fully revised version of the company’s renowned, highly informative inhaler testing brochure.

“Copley brings unrivalled expertise to every aspect of OINDP testing," said Mark Copley CEO. “We rigorously track changes in the regulatory landscape, and we listen to customers. The fully refreshed offering reflects these efforts. Our focus has been to make testing more straight forward and efficient, from bench space management to data analysis, equipment selection to test automation.  The new brochure guides customers through the increasingly complex world of OINDP testing and explains how to use all our products effectively, whether testing a generic in accordance with product-specific guidance or refining a test set-up for better in vitro-in vivo correlations (IVIVCs).” Refreshed ancillaries are characterised by clean lines, small footprint designs, and the latest touchscreen technology, complete with icon-based menus. Critical flow controllers (the TPK range), breath actuated controllers (the BAC 2100) and breathing simulators (the BRS range) have all been updated. A switch to quick release connectors on all equipment makes it easy to rapidly establish a leak-free test set-up. New introductions range from the ITW, a handling aid for the various pieces of equipment used during inhaler testing, to accessories that work with Copley’s automated shake and fire platforms to deliver highly reproducible nasal spray testing. The Copley brochure covers all aspects of DDU testing and APSD measurement, providing insight into the regulatory guidance and pharmacopoeial specifications associated with each. Advanced sections covering special applications and test set-ups for enhanced IVIVCs provide clear, concise advice on how to use the full range to optimise the testing of generic and innovator products, from R&D through to QC. “Continuous improvement is a Copley hallmark,” said Mark Copley. “Our new offering includes valuable upgrades that we’re confident can have a real impact on the day-to-day efficiency and integrity of OINDP testing. Whether you are looking for state-of-the-art equipment or insight on how to optimise testing strategies and lab practice, we can help.” Find out more about the full Copley range for OINDP testing at www.copleyscientific.com

CAPTION: Streamlined, intuitive ancillaries with touchscreen operation are a key feature of the upgraded Copley offering for OINDP testing.

ENDS

About Copley Scientific

Copley Scientific is widely recognised as the world’s leading manufacturer and supplier of inhaler test equipment and is a major provider of testing systems for other pharmaceutical dosage forms. The company also supplies equipment for detergent testing. Copley’s pharmaceutical product range includes test equipment for all types of orally inhaled and nasal drug products - metered-dose inhalers, dry powder inhalers, nebulisers and nasal sprays - with a particular focus on solutions for delivered dose uniformity and aerodynamic particle size distribution measurement. It also includes testers for tablets (dissolution, disintegration, friability and hardness) capsules, powders, suppositories, semisolids and transdermals. Used from R&D through to QC, this extensive range of equipment is supported by a full validation and aftersales service. Copley Scientific has offices in the UK and Switzerland and works in partnership with aerosol particle science experts MSP Corporation in North America; specialist distributors extend localised support across the world. This network provides expert help and training to every customer, directly enhancing the application of all Copley products.  www.copleyscientific.com  " ["post_title"]=> string(87) "Copley announces a major upgrade of the world’s ‘go to’ inhaler testing portfolio" ["post_excerpt"]=> string(0) "" ["post_status"]=> string(7) "publish" ["comment_status"]=> string(6) "closed" ["ping_status"]=> string(4) "open" ["post_password"]=> string(0) "" ["post_name"]=> string(78) "copley-announces-a-major-upgrade-of-the-worlds-go-to-inhaler-testing-portfolio" ["to_ping"]=> string(0) "" ["pinged"]=> string(0) "" ["post_modified"]=> string(19) "2021-07-07 15:32:28" ["post_modified_gmt"]=> string(19) "2021-07-07 14:32:28" ["post_content_filtered"]=> string(0) "" ["post_parent"]=> int(0) ["guid"]=> string(41) "https://www.copleyscientific.com/?p=12566" ["menu_order"]=> int(0) ["post_type"]=> string(4) "post" ["post_mime_type"]=> string(0) "" ["comment_count"]=> string(1) "0" ["filter"]=> string(3) "raw" }

object(WP_Post)#21502 (24) { ["ID"]=> int(11345) ["post_author"]=> string(1) "2" ["post_date"]=> string(19) "2021-01-29 08:51:04" ["post_date_gmt"]=> string(19) "2021-01-29 08:51:04" ["post_content"]=> string(4209) "14 January 2021; Nottingham, UK: Copley Scientific is now delivering e-Training, offering customers across the globe remote access to expert tuition on in vitro test methods for pharmaceutical dosage forms, notably for orally inhaled and nasal drug products (OINDPs). Customers can choose from a range of standard training packages or specify a bespoke session, with reliable, professional, live-streaming ensuring a high quality, interactive experience. Sessions on Installation Qualification and Operational Qualification (IQ/OQ) help customers to get new systems up and running while application-specific training ensures best practice. “Over the years we’ve welcomed many customers to Copley HQ for training, and we know that service is highly valued,” said Anna Sipitanou, Business Development Manager for Copley. “The global pandemic has rapidly brought about new ways of working for many of us. By establishing e-Training we can now offer expert input even when traditional visits aren’t practical. Going forward e-Training will mean greater flexibility, a choice between a visit or in-house learning, to suit individual requirements.” Copley, the world’s leading manufacturer and supplier of inhaler test equipment, is particularly well-known for training in the complex area of in vitro OINDP testing. Expert advice helps customers to fully utilise the company’s comprehensive range of OINDP test equipment and enhance the clinical relevance of in vitro data. However, the e-Training offering is extensive and also available for:

• testing of multiple pharmaceutical dosage forms including oral solid dosage, semi-solids, and suppositories
• a wide range of applications and test methods
• installation qualification/operational qualification (IQ/OQ) requirements; the validation processes required to bring new equipment into routine use.

Completion is certified for all courses. “Nothing should stop people efficiently validating their new equipment or accessing the training they need to get the most out of our products,” said Anna Sipitanou. “I’m delighted to have the e-Training service established and the team is looking forward to delivering the first sessions.” Contact sales@copleyscientific.co.uk to arrange your e-Training session.

CAPTION: Copley Scientific extends their training service options to include e-Training

ENDS

About Copley Scientific

Copley Scientific is widely recognised as the world’s leading manufacturer and supplier of inhaler test equipment and is a major provider of testing systems for other pharmaceutical dosage forms. The company also supplies equipment for detergent testing. Copley’s pharmaceutical product range includes test equipment for all types of orally inhaled and nasal drug products - metered-dose inhalers, dry powder inhalers, nebulisers and nasal sprays - with a particular focus on solutions for delivered dose uniformity and aerodynamic particle size distribution measurement. It also includes testers for tablets (dissolution, disintegration, friability and hardness), capsules, powders, suppositories, semisolids and transdermals. Used from R&D through to QC, this extensive range of equipment is supported by a full validation and aftersales service. Copley Scientific has offices in the UK and Switzerland and works in partnership with aerosol particle science experts MSP Corporation in North America; specialist distributors extend localised support across the world. This network provides expert help and training to every customer, directly enhancing the application of all Copley products.  www.copleyscientific.com" ["post_title"]=> string(61) "New e-Training service from Copley for pharmaceutical testing" ["post_excerpt"]=> string(0) "" ["post_status"]=> string(7) "publish" ["comment_status"]=> string(6) "closed" ["ping_status"]=> string(4) "open" ["post_password"]=> string(0) "" ["post_name"]=> string(61) "new-e-training-service-from-copley-for-pharmaceutical-testing" ["to_ping"]=> string(0) "" ["pinged"]=> string(0) "" ["post_modified"]=> string(19) "2021-02-10 17:26:03" ["post_modified_gmt"]=> string(19) "2021-02-10 17:26:03" ["post_content_filtered"]=> string(0) "" ["post_parent"]=> int(0) ["guid"]=> string(41) "https://www.copleyscientific.com/?p=11345" ["menu_order"]=> int(0) ["post_type"]=> string(4) "post" ["post_mime_type"]=> string(0) "" ["comment_count"]=> string(1) "0" ["filter"]=> string(3) "raw" }

object(WP_Post)#21501 (24) { ["ID"]=> int(5238) ["post_author"]=> string(1) "2" ["post_date"]=> string(19) "2020-07-16 10:28:03" ["post_date_gmt"]=> string(19) "2020-07-16 09:28:03" ["post_content"]=> string(3968) "20 April 2020; Nottingham, UK: Copley Scientific will shortly begin the company’s inaugural series of technical webinars, offering valuable, easy to understand overviews on key aspects of inhaler testing. Copley is the world’s leading manufacturer and supplier of inhaler test equipment and exemplary training is a hallmark of the company’s customer-centric approach. Each ‘Quick guide to…’ webinar will focus on the specific device type to be tested - metered dose inhalers (MDIs), dry powder inhalers (DPIs) or nebulisers - or a critical area of interest such as regulatory updates and achieving better in vitro-in vivo correlations (IVIVCs). The new series will run over the coming quarter, building to an important resource for both novice and experienced researchers. Register here to attend the first webinar, on MDIs, at 10:00 AM (BST) on April 29th, which will be delivered by Anna Sipitanou, Business Development Manager and one of Copley’s most knowledgeable trainers. “I’m looking forward to delivering the first in this webinar series,” said Anna Sipitanou, “since I know we’ll be able to share a lot of information that customers will find helpful. The aim is to provide an up-to-date overview in each area. Those new to inhaler testing can use this as an introduction, while those with more experience can brush up on the basics and learn about new developments. Once complete the full series will usefully complement the comprehensive, in-house and tailored training we provide to directly meet specific customer requirements.” The webinars will draw on Copley’s extensive knowledge of the regulatory requirements for both delivered dose uniformity testing and aerodynamic particle size distribution measurement and practical experience of helping laboratory analysts implement effective testing strategies. “Topics on the agenda for the initial MDI webinar include regulatory in vitro testing requirements, common issues encountered in testing and troubleshooting,” said Anna Sipitanou. “All the webinars will be around an hour long and conclude with time for questions. There’s no charge to attend so I’m hoping plenty of people will take the opportunity to advance their learning and understanding.”

CAPTION: Copley Scientific launches their inaugural webinar series for inhaler testing

About Copley Scientific

Copley Scientific is widely recognised as the world’s leading manufacturer and supplier of inhaler test equipment and is a major provider of testing systems for other pharmaceutical dosage forms. The company also supplies equipment for detergent testing. Copley’s pharmaceutical product range includes test equipment for all types of orally inhaled and nasal drug products - metered-dose inhalers, dry powder inhalers, nebulisers and nasal sprays - with a particular focus on solutions for delivered dose uniformity and aerodynamic particle size distribution measurement. It also includes testers for tablets (dissolution, disintegration, friability and hardness) capsules, powders, suppositories, semisolids and transdermals. Used from R&D through to QC, this extensive range of equipment is supported by a full validation and aftersales service. Copley Scientific has offices in the UK and Switzerland and works in partnership with aerosol particle science experts MSP Corporation in North America; specialist distributors extend localised support across the world. This network provides expert help and training to every customer, directly enhancing the application of all Copley products. www.copleyscientific.com" ["post_title"]=> string(55) "Copley launches a new webinar series on inhaler testing" ["post_excerpt"]=> string(0) "" ["post_status"]=> string(7) "publish" ["comment_status"]=> string(6) "closed" ["ping_status"]=> string(4) "open" ["post_password"]=> string(0) "" ["post_name"]=> string(55) "copley-launches-a-new-webinar-series-on-inhaler-testing" ["to_ping"]=> string(0) "" ["pinged"]=> string(0) "" ["post_modified"]=> string(19) "2021-02-10 16:43:25" ["post_modified_gmt"]=> string(19) "2021-02-10 16:43:25" ["post_content_filtered"]=> string(0) "" ["post_parent"]=> int(0) ["guid"]=> string(40) "https://www.copleyscientific.com/?p=5238" ["menu_order"]=> int(0) ["post_type"]=> string(4) "post" ["post_mime_type"]=> string(0) "" ["comment_count"]=> string(1) "0" ["filter"]=> string(3) "raw" }

object(WP_Post)#21482 (24) { ["ID"]=> int(5202) ["post_author"]=> string(1) "2" ["post_date"]=> string(19) "2020-07-15 21:35:55" ["post_date_gmt"]=> string(19) "2020-07-15 20:35:55" ["post_content"]=> string(4191) "01 April 2020; Nottingham, UK: Copley Scientific, a global supplier of pharmaceutical testing equipment, has appointed Welch Materials Inc. as exclusive distributors for its complete portfolio of tablet, powder, suppository, and semisolids testing products. The appointment will bring customers in this vital region enhanced sales and support service delivered by dedicated, knowledgeable local experts. A well-established company with more than 17 years’ experience in the Chinese instrument market, Welch Materials is headquartered in Songjiang, Shanghai. The company has over 230 employees, with approximately 50% qualified to graduate/post-graduate level, and a sales network that extends across all provinces of China. Welch Materials’ leading position in the Chinese HPLC (High Pressure Liquid Chromatography) market makes them well-placed to support Copley customers across the pharmaceutical industry. “China is a key market for us, and I’m delighted to announce the appointment of such a strong partner in the region,” said Mr Mark Copley, CEO of Copley. “Welch Materials has excellent product demonstration and training facilities at its headquarters in Songjiang, and equally importantly, an established team of scientists and engineers with highly relevant knowledge. We’re looking forward to working seamlessly with Welch Materials to bring the completely new product platform for pharmaceutical testing to customers across China.” Copley’s new platform for pharmaceutical testing provides productive, cost-efficient solutions for routine analysis, including tablet dissolution, disintegration, friability, hardness and thickness testing. Extremely reliable and easy-to-use, these systems deliver excellent data quality at an accessible price. Welch Materials will sell and support the complete pharmaceutical testing range, along with Copley’s detergent testing products. The established Chinese partner for Copley’s globally renowned inhaler testing equipment remains unchanged. “Copley has a compelling solution for customers looking for well-designed, reliable kit for day-to-day pharmaceutical testing and we’re committed to supporting it with exemplary customer service,” said Mr Copley. “The appointment of Welch Materials underlines that commitment and will deliver important benefits to our Chinese customers over the long term.”

CAPTION: Copley appoints leading analytical instrumentation company Welch Materials as distributor for tablet, powder, suppository, semisolid and detergent testing products in China

 

About Copley Scientific

Copley Scientific is widely recognised as the world’s leading manufacturer and supplier of inhaler test equipment and is a major provider of testing systems for other pharmaceutical dosage forms. The company also supplies equipment for detergent testing. Copley’s pharmaceutical product range includes test equipment for all types of orally inhaled and nasal drug products - metered-dose inhalers, dry powder inhalers, nebulizers and nasal sprays - with a particular focus on solutions for delivered dose uniformity and aerodynamic particle size distribution measurement. It also includes testers for tablets (dissolution, disintegration, friability and hardness) capsules, powders, suppositories, semisolids and transdermals. Used from R&D through to QC, this extensive range of equipment is supported by a full validation and aftersales service. Copley Scientific has offices in the UK and Switzerland and works in partnership with aerosol particle science experts MSP Corporation in North America; specialist distributors extend localised support across the world. This network provides expert help and training to every customer, directly enhancing the application of all Copley products. www.copleyscientific.com" ["post_title"]=> string(38) "Copley adds a new distributor in China" ["post_excerpt"]=> string(0) "" ["post_status"]=> string(7) "publish" ["comment_status"]=> string(6) "closed" ["ping_status"]=> string(4) "open" ["post_password"]=> string(0) "" ["post_name"]=> string(38) "copley-adds-a-new-distributor-in-china" ["to_ping"]=> string(0) "" ["pinged"]=> string(0) "" ["post_modified"]=> string(19) "2021-02-10 16:46:37" ["post_modified_gmt"]=> string(19) "2021-02-10 16:46:37" ["post_content_filtered"]=> string(0) "" ["post_parent"]=> int(0) ["guid"]=> string(40) "https://www.copleyscientific.com/?p=5202" ["menu_order"]=> int(0) ["post_type"]=> string(4) "post" ["post_mime_type"]=> string(0) "" ["comment_count"]=> string(1) "0" ["filter"]=> string(3) "raw" }

object(WP_Post)#21500 (24) { ["ID"]=> int(4717) ["post_author"]=> string(1) "2" ["post_date"]=> string(19) "2020-02-06 09:05:07" ["post_date_gmt"]=> string(19) "2020-02-06 09:05:07" ["post_content"]=> string(4279) "6 February 2020; Nottingham, UK: Copley Scientific, a company renowned for high quality pharmaceutical testing equipment, begins the decade with a major rebrand complete with a new brand promise – Innovative – Compliant – Trusted – to capture the defining characteristics of Copley products. The rebrand reflects the evolution of the company, following a period of sustained growth through acquisition and recruitment, and will be immediately apparent in a newly launched, comprehensively upgraded pharmaceutical testing platform. Smart, easy-to-use, and underpinned by the new brand promise, these products present a compelling proposition for high productivity, cost-efficient everyday pharmaceutical testing. The company’s website has also been substantially upgraded and a new set of clear, informative product brochures released. A valuable resource for all customers, the new website offers detailed technical information to support testing to the standards defined by the regulators and pharmacopoeias and incorporates a new video giving insight into the company’s global operations. The new pharmaceutical testing platform meets customer requirements for reliable, cost-effective solutions for routine analysis, including tablet dissolution, disintegration, friability and hardness testing that deliver high quality data. Key features of the new range include touchscreens that simplify operation to the point of one-touch-start testing, flexible and extensive data reporting options (to PC or printer), and durable, streamlined designs that ease and minimise cleaning and maintenance. These features are also evident in the newly updated Copley Tergotometer, an efficient, bench-top instrument for detergent testing. New product additions to the company’s extensive, market-leading inhaler testing product range are due for release in the coming months. The new promise clearly communicates Copley’s enduring values and the ongoing focus of the recently expanded team. Innovation and a commitment to the highest engineering standards deliver solutions that answer directly to well-understood customer requirements. Productivity and efficiency are critical but so too is easing the compliance burden associated with testing in a highly regulated environment. As a family business, Copley’s long and distinguished reputation underpins customer trust in its products and the results they deliver. To find out more about what the brand promise means in practice and about the efficiency and ease of use of the new pharmaceutical testing equipment, visit the new website: www.copleyscientific.com

CAPTION: Copley advert for newly released Pharmaceutical Testing platform

About Copley Scientific

Copley Scientific is widely recognised as the world’s leading manufacturer and supplier of inhaler test equipment and is a major provider of testing systems for other pharmaceutical dosage forms. The company also supplies equipment for detergent testing. Copley’s pharmaceutical product range includes test equipment for all types of orally inhaled and nasal drug products - metered-dose inhalers, dry powder inhalers, nebulisers and nasal sprays - with a particular focus on solutions for delivered dose uniformity and aerodynamic particle size distribution measurement. It also includes testers for tablets (dissolution, disintegration, friability and hardness) capsules, powders, suppositories, semisolids and transdermals. Used from R&D through to QC, this extensive range of equipment is supported by a full validation and aftersales service. Copley Scientific has offices in the UK and Switzerland and works in partnership with aerosol particle science experts MSP Corporation in North America; specialist distributors extend localised support across the world. This network provides expert help and training to every customer, directly enhancing the application of all Copley products. www.copleyscientific.com" ["post_title"]=> string(109) "Innovative – Compliant – Trusted: Copley marks a new decade with a major rebrand and a new product range." ["post_excerpt"]=> string(0) "" ["post_status"]=> string(7) "publish" ["comment_status"]=> string(6) "closed" ["ping_status"]=> string(4) "open" ["post_password"]=> string(0) "" ["post_name"]=> string(99) "innovative-compliant-trusted-copley-marks-a-new-decade-with-a-major-rebrand-and-a-new-product-range" ["to_ping"]=> string(0) "" ["pinged"]=> string(0) "" ["post_modified"]=> string(19) "2020-06-18 15:46:09" ["post_modified_gmt"]=> string(19) "2020-06-18 14:46:09" ["post_content_filtered"]=> string(0) "" ["post_parent"]=> int(0) ["guid"]=> string(42) "https://www.copleyscientific.co.uk/?p=4717" ["menu_order"]=> int(0) ["post_type"]=> string(4) "post" ["post_mime_type"]=> string(0) "" ["comment_count"]=> string(1) "0" ["filter"]=> string(3) "raw" }

object(WP_Post)#21496 (24) { ["ID"]=> int(4662) ["post_author"]=> string(1) "1" ["post_date"]=> string(19) "2019-11-28 20:41:47" ["post_date_gmt"]=> string(19) "2019-11-28 20:41:47" ["post_content"]=> string(4365) "28 November 2019; Nottingham, UK: New recruits to the Copley Scientific team are helping to bring innovative pharmaceutical test equipment to customers faster, as the company invests heavily in a product pipeline matched to industry needs. Edward Brundrett, a new technical sales executive is working to enhance every aspect of the sales process while Mark Lo brings fresh advanced mechanical engineering knowledge to the design team. “We’re committed to providing a sales team that combines the technical expertise and responsiveness needed to serve our customers effectively and we are delighted to welcome Edward to it,” said Richard Postlethwaite, Chief Operating Officer, Copley Scientific. “As global leaders in testing equipment for inhalers and other dosage forms, we routinely break new ground with innovative products for faster, more reliable and more patient representative testing. Our knowledgeable sales team supports customers in identifying which products will help them to best address the challenges they face, and we are committed to investing in its growth and evolution.” With a reputation for continuous improvement, Copley has recently added market-leading automation expertise to its portfolio with the acquisition of Novi Systems. This brings a new dimension to the design process. “Mark joins an experienced and highly successful design team at a particularly exciting time,” continues Richard Postlethwaite. “The smart use of automation has significant potential to reduce the variability associated with inhaler testing, which, due to its complexity, remains predominantly manual in most labs. And, of course, to boost productivity. A defining focus for the design team is the evolution of our extensive portfolio to allow customers to answer to increasingly complex regulatory requirements, as efficiently as possible.” Copley designs and manufactures the equipment required for testing metered-dose inhalers, dry powder inhalers, nebuliser and nasal sprays, as well as tablets, capsules, suppositories, transdermals, powders, granules, creams and ointments, from R&D through to QC. An unrivalled understanding of the practicalities of testing, in combination with a track record of collaborating closely with the industry in order to precisely define requirements, underpins the success of the current, broad product range. “It is extremely rewarding to be working on products that we know will bring real value to our customers,” said Richard Postlethwaite “and we look forward to delivering them with exemplary levels of customer service.”

CAPTION: New Technical Sales Executive, Edward Brundrett (middle) and new Design Engineer, Mark Lo (right) welcomed to the company by Chief Operating Officer, Richard Postlethwaite (left).

About Copley Scientific

Copley Scientific is widely recognised as the world’s leading manufacturer and supplier of inhaler test equipment and is a major provider of testing systems for other pharmaceutical dosage forms. The company also supplies equipment for detergent testing. Copley Scientific’s pharmaceutical product range includes test equipment for all types of orally inhaled and nasal drug products - metered-dose inhalers, dry powder inhalers, nebulisers and nasal sprays - with a particular focus on solutions for delivered dose uniformity and aerodynamic particle size distribution measurement. It also includes testers for tablets (dissolution, disintegration, friability and hardness) capsules, powders, suppositories, semisolids and transdermals. Used from R&D through to QC, this extensive range of equipment is supported by a full validation and aftersales service. Copley Scientific has offices in the UK and Switzerland and works in partnership with aerosol particle science experts MSP Corporation in North America; specialist distributors extend localised support across the world. This network provides expert help and training to every customer, directly enhancing the application of all Copley Scientific products. www.copleyscientific.com" ["post_title"]=> string(140) "Delivering the next generation of pharmaceutical testing equipment: Copley Scientific welcomes new engineers into the sales and design teams" ["post_excerpt"]=> string(0) "" ["post_status"]=> string(7) "publish" ["comment_status"]=> string(6) "closed" ["ping_status"]=> string(4) "open" ["post_password"]=> string(0) "" ["post_name"]=> string(139) "delivering-the-next-generation-of-pharmaceutical-testing-equipment-copley-scientific-welcomes-new-engineers-into-the-sales-and-design-teams" ["to_ping"]=> string(0) "" ["pinged"]=> string(0) "" ["post_modified"]=> string(19) "2020-05-06 12:36:47" ["post_modified_gmt"]=> string(19) "2020-05-06 11:36:47" ["post_content_filtered"]=> string(0) "" ["post_parent"]=> int(0) ["guid"]=> string(34) "https://copley.fifteen.dev/?p=4662" ["menu_order"]=> int(0) ["post_type"]=> string(4) "post" ["post_mime_type"]=> string(0) "" ["comment_count"]=> string(1) "0" ["filter"]=> string(3) "raw" }